Mutation Can Trigger Parkinson’s Outside the Brain, Study Finds
The most common gene mutation in Parkinson’s triggers disease outside the brain by changing the body’s immune response to…
Articles by José Lopes, PhD
New PET Tracer with Potential to Diagnose Parkinson’s to Be Tested in First-in-Human Study
An innovative Positron Emission Tomography (PET) tracer that has the potential to diagnose Parkinson’s disease will soon be tested in humans…
Partnership Aims to Move Cannabis-Based Treatments for Parkinson’s into Clinical Testing
India Globalization Capital (IGC) has joined with the nonprofit Parkinson’s Institute and Clinical Center (PICC) with the goal of moving cannabinoid-based treatments…
Nanoparticle-based DNA Barcoding Could Be Used to Test Gene Therapies, Study Shows
A new DNA barcoding technique using nanoparticles could be used for large-scale testing of gene therapies for diseases such as…
Measuring Levels of Critical Protein May Aid Earlier Diagnosis of Parkinson’s
A new way to measure levels of a critical protein in Parkinson’s disease could lead to improved diagnosis and treatments. Using…
Tears May Be Used as Biological Marker to Detect Parkinson’s Disease
Tears may be used to diagnose Parkinson’s disease, according to preliminary findings of a study that will be presented at the…
Excessive Calcium Levels in Brain May Play Role in Parkinson’s Disease
Excessive levels of calcium in the brain may trigger the formation of toxic protein clumps that typify Parkinson’s disease. This finding…
Blood Caffeine Levels May Help Diagnose Early Parkinson’s Disease, Study Reports
Parkinson’s patients have lower blood levels of caffeine and its byproducts after consuming the stimulant, suggesting that caffeine could…
Chan Zuckerberg Initiative Calls for Parkinson’s Research Proposals
The Chan Zuckerberg Initiative is accepting funding applications from researchers who want to do basic science projects on neurodegeneration. The…
FDA Accepts New Drug Application for Acorda’s Parkinson’s Therapy Inbrija
The U.S. Food and Drug Administration has accepted Acorda Therapeutics’ New Drug Application for Inbrija (CVT-301)Â as a potential…